ASCO: NALIRIFOX Improves Survival in Patients with Previously Untreated Metastatic Pancreatic Cancer
https://unsplash.com/photos/tV-RX0beDp8

ASCO: NALIRIFOX Improves Survival in Patients with Previously Untreated Metastatic Pancreatic Cancer

  The American Society of Clinical Oncology (ASCO) held its Annual Meeting from May 31 - June 4, 2023. During the meeting, attendees discussed a variety of oncological topics, trends,…

Continue Reading ASCO: NALIRIFOX Improves Survival in Patients with Previously Untreated Metastatic Pancreatic Cancer